Think about what we're doing to combat this disease. Foundation is using high throughput screening to analyze <b>thousands of compounds in a relatively short amount of time</b>. They're pursuing <b>many possible therapies </b>to mitigate symptoms or correct the underlying defect. You've got the CF gene therapy consortium in Britain, which is about to begin gene therapy trials (I read somewhere that this is the <b>largest gene therapy group </b>devoted to a single disease in existence). It sounds kind of corny, I know, but we're working together too.